Mega Lifesciences PCL (BKK: MEGA)

Mega Lifesciences PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,909	2,357	2,453	2,198	1,006	1,248
Short-Term Investments	6.15	365.05	345.55	342.64	225.85	219.51
Cash & Short-Term Investments	2,915	2,722	2,799	2,540	1,232	1,467
Cash Growth	18.94%	-2.76%	10.18%	106.14%	-16.02%	55.95%
Accounts Receivable	2,970	3,314	3,107	2,557	2,507	2,539
Other Receivables	294.61	158.28	180.15	164.18	74.68	77.5
Receivables	3,265	3,472	3,287	2,721	2,581	2,616
Inventory	3,118	3,377	4,109	3,823	3,489	2,856
Prepaid Expenses	-	58.59	60.14	53.43	43.95	50.92
Other Current Assets	274.08	360.23	334.95	162.8	240.19	239.14
Total Current Assets	9,572	9,990	10,590	9,301	7,587	7,230
Property, Plant & Equipment	2,203	2,225	2,151	2,103	2,214	1,771
Long-Term Investments	38.41	221.15	222.88	214.79	194.47	240.57
Goodwill	458.71	456.24	465.88	476.25	437.32	199.42
Other Intangible Assets	874.44	862.23	863.31	876.89	875	792.17
Long-Term Deferred Tax Assets	258.07	278.95	250.32	210.41	175.03	115.34
Other Long-Term Assets	128.13	81	103.49	89.75	74.27	184.94
Total Assets	13,533	14,115	14,646	13,272	11,557	10,533
Accounts Payable	1,841	1,925	2,793	2,527	2,048	2,020
Accrued Expenses	873.93	1,150	1,604	1,283	823.52	914.5
Short-Term Debt	168.75	76	229.18	168.18	499.49	888.31
Current Portion of Leases	64.63	43.78	82.96	56.21	36.67	1.32
Current Income Taxes Payable	28.23	108.45	204.18	185.86	160.73	108.96
Other Current Liabilities	909.11	1,133	624.44	633.02	660.61	225.49
Total Current Liabilities	3,886	4,437	5,538	4,853	4,229	4,158
Long-Term Leases	144.65	132.06	108.73	131.94	111.31	0.85
Long-Term Deferred Tax Liabilities	0	2.14	-	-	0.98	1.52
Other Long-Term Liabilities	-	-	-	-	0.33	-
Total Liabilities	4,295	4,813	5,870	5,247	4,578	4,358
Common Stock	435.94	435.94	435.94	435.94	435.94	435.94
Additional Paid-In Capital	2,305	2,305	2,305	2,305	2,305	2,305
Retained Earnings	7,188	7,210	6,655	5,766	4,752	4,041
Comprehensive Income & Other	-690.63	-648.11	-618.9	-503.97	-534.41	-606.67
Total Common Equity	9,238	9,302	8,777	8,003	6,958	6,175
Minority Interest	0.14	0.02	0.07	22.3	21.29	0.1
Shareholders' Equity	9,238	9,302	8,777	8,025	6,979	6,175
Total Liabilities & Equity	13,533	14,115	14,646	13,272	11,557	10,533
Total Debt	378.02	251.84	420.87	356.33	647.47	890.48
Net Cash (Debt)	2,537	2,470	2,378	2,184	584.84	576.95
Net Cash Growth	14.83%	3.86%	8.89%	273.44%	1.37%	-
Net Cash Per Share	2.91	2.83	2.73	2.50	0.67	0.66
Filing Date Shares Outstanding	871.87	871.87	871.87	871.87	871.87	871.87
Total Common Shares Outstanding	871.87	871.87	871.87	871.87	871.87	871.87
Working Capital	5,686	5,553	5,052	4,448	3,358	3,072
Book Value Per Share	10.60	10.67	10.07	9.18	7.98	7.08
Tangible Book Value	7,904	7,984	7,447	6,650	5,645	5,183
Tangible Book Value Per Share	9.07	9.16	8.54	7.63	6.47	5.95
Land	-	-	-	-	-	250.61
Buildings	-	-	-	-	-	868.12
Machinery	-	-	-	-	-	1,511
Construction In Progress	-	-	-	-	-	324.07
Leasehold Improvements	-	-	-	-	-	32.88

Source: S&P Capital IQ. Standard template. Financial Sources.